van't Veer LJ - Search Results

1

Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma.

Glas AM, Knoops L, Delahaye L, Kersten MJ, Kibbelaar RE, Wessels LA, van Laar R, van Krieken JH, Baars JW, Raemaekers J, Kluin PM, van't Veer LJ, de Jong D. Glas AM, et al. J Clin Oncol. 2007 Feb 1;25(4):390-8. doi: 10.1200/JCO.2006.06.1648. Epub 2007 Jan 2. J Clin Oncol. 2007. PMID: 17200149 Free article.

2

Mutational activation of the K-ras oncogene and the effect of chemotherapy in advanced adenocarcinoma of the lung: a prospective study.

Rodenhuis S, Boerrigter L, Top B, Slebos RJ, Mooi WJ, van't Veer L, van Zandwijk N. Rodenhuis S, et al. J Clin Oncol. 1997 Jan;15(1):285-91. doi: 10.1200/JCO.1997.15.1.285. J Clin Oncol. 1997. PMID: 8996154

3

Oligoclonal peripheral T-cell lymphocytosis as a result of aberrant T-cell development in a cortical thymoma.

de Jong D, Richel DJ, Schenkeveld C, Boerrigter L, van 't Veer LJ. de Jong D, et al. Diagn Mol Pathol. 1997 Aug;6(4):244-8. doi: 10.1097/00019606-199708000-00009. Diagn Mol Pathol. 1997. PMID: 9360846

4

Multiple malignancies in a patient with bilateral retinoblastoma.

Ceha HM, Balm AJ, de Jong D, van 't Veer LJ. Ceha HM, et al. J Laryngol Otol. 1998 Feb;112(2):189-92. doi: 10.1017/s0022215100140289. J Laryngol Otol. 1998. PMID: 9578885

5

The detection of minimal numbers of contaminating epithelial tumor cells in blood or bone marrow: use, limitations and future of RNA-based methods.

Lambrechts AC, van 't Veer LJ, Rodenhuis S. Lambrechts AC, et al. Ann Oncol. 1998 Dec;9(12):1269-76. doi: 10.1023/a:1008445604263. Ann Oncol. 1998. PMID: 9932154 Free article. Review.

6

The microarray way to tailored cancer treatment.

Van 't Veer LJ, De Jong D. Van 't Veer LJ, et al. Nat Med. 2002 Jan;8(1):13-4. doi: 10.1038/nm0102-13. Nat Med. 2002. PMID: 11786894 No abstract available.

7

Gene expression profiling predicts clinical outcome of breast cancer.

van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH. van 't Veer LJ, et al. Nature. 2002 Jan 31;415(6871):530-6. doi: 10.1038/415530a. Nature. 2002. PMID: 11823860

8

Phase I clinical and pharmacologic study of chronic oral administration of the farnesyl protein transferase inhibitor R115777 in advanced cancer.

Crul M, de Klerk GJ, Swart M, van't Veer LJ, de Jong D, Boerrigter L, Palmer PA, Bol CJ, Tan H, de Gast GC, Beijnen JH, Schellens JH. Crul M, et al. J Clin Oncol. 2002 Jun 1;20(11):2726-35. doi: 10.1200/JCO.2002.09.116. J Clin Oncol. 2002. PMID: 12039935 Clinical Trial.

9

Detection of circulating breast tumor cells by differential expression of marker genes.

Bosma AJ, Weigelt B, Lambrechts AC, Verhagen OJ, Pruntel R, Hart AA, Rodenhuis S, van 't Veer LJ. Bosma AJ, et al. Clin Cancer Res. 2002 Jun;8(6):1871-7. Clin Cancer Res. 2002. PMID: 12060630

10

A gene-expression signature as a predictor of survival in breast cancer.

van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, Parrish M, Atsma D, Witteveen A, Glas A, Delahaye L, van der Velde T, Bartelink H, Rodenhuis S, Rutgers ET, Friend SH, Bernards R. van de Vijver MJ, et al. N Engl J Med. 2002 Dec 19;347(25):1999-2009. doi: 10.1056/NEJMoa021967. N Engl J Med. 2002. PMID: 12490681 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

388 results

Search Page